Children’s Health Challenge Programming

Event Page

Panel: Pediatric Rare Disease

Melindah Sharma

Event Co-Chair, Moderator
Managing Director, Manatt Health

Read More
Amber Freed

Panelist
CEO and Founder, SLC6A1 Connect

Read More
Hannah Aura Shoval, MD, MBA

Panelist
Chief of Pediatric Rehabilitation Medicine

Read More
Terry Jo Bichell

Panelist
CEO and Founder, COMBINEDBrain

Read More

Panel: Accelerating Pediatric Innovation

John Parker

Moderator

Managing Partner, Springhood, Hood Foundation

Read More
Orin Herskowitz

Panelist

President, Mussallem CHD Alliance

Read More
Janna Patterson, MD, MPH

Panelist
Chief Education and Global Health Officer, AAP

Read More
Vasum Peiris, MD, MPH

Panelist
Former Chief Medical Officer of Pediatrics, FDA

Read More

Meet Our Judges.

Rachel Butler - President, Catalytic Impact Foundation, Event Co-Chair

Richard Lipkin - Founder, Catalytic Impact Foundation

Rob Wolk - Board Chair, Catalytic Impact Foundation

Melindah Sharma - Managing Director, Manatt Health, Co-Chair

John Parker - Vice President, Hood Foundation

Fireside Chat: Children’s Health in the Digital Age

Dr. Chelsea Clinton, Vice Chair, Clinton Foundation

Chelsea Clinton is an advocate, storyteller, investor, mentor, teacher, and most importantly, mom to her three kids. As vice chair of the Clinton Foundation, Chelsea works alongside the Foundation’s leadership and partners to improve global health and wellness, increase opportunity for girls and women, create economic opportunity and growth, and inspire emerging leaders across the United States and around the world. A longtime public health advocate, Chelsea also serves as vice chair of the Clinton Health Access Initiative and uses her platform to increase awareness around issues such as vaccine hesitancy, childhood obesity, and health equity. In addition to her Foundation work, Chelsea is the co-founder of Metrodora Ventures, she teaches at Columbia University’s Mailman School of Public Health and has written several books for young adults and readers, including the #1 New York Times bestselling She Persisted. Chelsea holds a Bachelor of Arts from Stanford, a Master of Public Health from Columbia’s Mailman School of Public Health, and both a Master of Philosophy and a Doctorate in international relations from Oxford University.

Fireside Chat Moderated by Dr. Andrew Racine, President, American Academy of Pediatrics

Dr. Racine was born in New York City, attended Harvard College and subsequently spent a year in Tanzania before returning to complete his MD, PhD (economics) at NYU and his pediatric training at the Boston Children’s Hospital. He is currently the System Senior Vice-President of the Montefiore Health System and Executive Director of the Montefiore Medical Group. He holds appointments as Professor of Pediatrics at the Albert Einstein College of Medicine (AECOM) and was previously a Research Associate at the National Bureau of Economic Research (NBER) in Manhattan. His research collaborations at the NBER have involved the impact of a variety of public health programs on child health outcomes. He has also been heavily involved in child health advocacy at the local and national level with the American Academy of Pediatrics having served on the AAP’s national Committee on Child Health Financing and Chair of the National Task Force of Poverty and Child Health. Dr. Racine was recently appointed to the Board of Trustees of the NBER, sits on the Board of the New York Academy of Medicine, and is currently the President of the American Academy of Pediatrics.

Our Five Finalists.

Unravel Biosciences

Unravel’s dedicated team brings effective drugs to patients based on technology developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University, and forms the keystone to building a new paradigm for accelerating drug development at lower cost and with lower risk.

Regatta Bio

At Regatta Bio, we are advancing the next generation of regulatory T cell (Treg) therapies to address some of the most pressing challenges in immune health. Our mission is to develop scalable, targeted, and durable treatments for conditions like chronic Graft-versus-Host Disease, solid organ rejection, and autoimmune disorders by overcoming the limitations of traditional immunosuppression.

Siloam Vision

Siloam’s vision of the future has always been simple: to reduce preventable blindness and improve health of populations worldwide. This commitment stems from our experiences providing eye care to blind children in developing countries, where we discovered the profound impact of accessible vision care.

Tympanogen

Tympanogen modernizes procedures for ENT surgeons through thoughtfully designed solutions, streamlined workflows, and transformative patient experiences. Their novel Per-Fex system is a nonsurgical eardrum repair treatment that replaces traditional tympanoplasty with a clinic-based procedure.

AVaTAR MedTech

AVaTAR MedTech’s inaugural product, AVaTAR (Aortic Valve Trileaflet Autologous Reconstruction), stands as a groundbreaking surgical method and set of medical devices designed to reconstruct the aortic or the pulmonary valve in children and adults with autologous tissue.